3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
24
Pancreatic Neoplasms
14
Stomach Neoplasms
12
Rectal Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
9
Esophageal Neoplasms
9
Colonic Neoplasms
9
Neoplasms
7
Adenocarcinoma Of Esophagus
7
Urinary Bladder Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Cholangiocarcinoma
4
Breast Neoplasms
4
Anus Neoplasms
4
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
2
Melanoma
2
Hepatoblastoma
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Clinical Stage I Gastric Cancer AJCC v8
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Urachal cancer
1
Unresectable Colorectal Cancer
1
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Locally Advanced Pancreatic Cancer
×
Fluorouracil
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled